Abdiche Yasmina N, Malashock Dan S, Pinkerton Alanna, Pons Jaume
Rinat Laboratories, Biotherapeutics and Bioinnovation Center (BBC), Pfizer Inc., South San Francisco, CA 94080, USA.
Anal Biochem. 2009 Mar 15;386(2):172-80. doi: 10.1016/j.ab.2008.11.038. Epub 2008 Dec 7.
We demonstrate the use of label-free real-time optical biosensors in competitive binding assays by epitope binning a panel of antibodies. We describe three assay orientations that we term in tandem, premix, and classical sandwich blocking, and we perform each of them on three platforms: ForteBio's Octet QK, Bio-Rad's ProteOn XPR36, and GE Healthcare's Biacore 3000. By testing whether antibodies block one another's binding to their antigen in a pairwise fashion, we establish a blocking profile for each antibody relative to the others in the panel. The blocking information is then used to create "bins" of antibodies with similar epitopes. The advantages and disadvantages of each biosensor, factors to consider when deciding on the most appropriate blocking assay orientation for a particular interaction system, and tips for dealing with ambiguous data are discussed. The data from our different assay orientations and biosensors agree very well, establishing these machines as valuable tools for characterizing antibody epitopes and multiprotein complexes of biological significance.
我们通过对一组抗体进行表位分组,展示了无标记实时光学生物传感器在竞争性结合分析中的应用。我们描述了三种分析方向,分别称为串联、预混和经典夹心阻断,并在三个平台上进行了每种分析:ForteBio的Octet QK、Bio-Rad的ProteOn XPR36和GE Healthcare的Biacore 3000。通过测试抗体是否以两两配对的方式相互阻断与抗原的结合,我们建立了每组中每个抗体相对于其他抗体的阻断图谱。然后,利用该阻断信息创建具有相似表位的抗体“分组”。讨论了每种生物传感器的优缺点、为特定相互作用系统确定最合适的阻断分析方向时需要考虑的因素,以及处理模糊数据的技巧。我们不同分析方向和生物传感器的数据非常吻合,确立了这些仪器作为表征具有生物学意义的抗体表位和多蛋白复合物的宝贵工具。